Showing posts with label
Citadel Advisors
.
Show all posts
Showing posts with label
Citadel Advisors
.
Show all posts
Friday, June 27, 2025
When the tech "hits the fan" so to speak, who might bid for Cabaletta Bio and their cutting edge technology?
›
Cabaletta Bio is a compelling acquisition target in a growing niche— cell therapy for autoimmune diseases . Its unique platform, strong e...
›
Home
View web version
